|
⚲
|
| Sandra Gurrola | |
|---|---|
| Firm | |
| Address | 1035 Cambridge Street Suite 18A Cambridge, Ma 02141 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Ernexa Therapeutics Inc | 021-543509 | Executive Officer | 7.2 M of 7.2 M |
||
| Eterna Therapeutics Inc | 021-529370 | Executive Officer | 1.1 M of 1.1 M |
||
| Eterna Therapeutics Inc | 021-529371 | Executive Officer | 3.9 M of 3.9 M |
||
| Eterna Therapeutics Inc | 021-500205 | Executive Officer | 7.8 M of 9.2 M |
||
| Eterna Therapeutics Inc | 021-487908 | Executive Officer | 8.7 M of 8.7 M |
||
| Eterna Therapeutics Inc | 021-487907 | Executive Officer | 8.7 M of 8.7 M |
||
| Eterna Therapeutics Inc | 021-467803 | Executive Officer | 7.7 M of 7.7 M |
||
| Brooklyn Immunotherapeutics Inc | 021-438648 | Executive Officer | 12.0 M of 12.0 M |
||